University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
NCT Number: NCT03237195
Most patients with cancer of the head and neck are offered surgical resection of the primary tumor. In order to determine how the tumor will eventually behave, along with the resection of the primary tumor, lymph nodes present in the neck are also dissected. Different institutes have different protocol on handling of the specimen that is received by the pathology labs after dissection of the neck. The investigators intend to analyze the protocol that they use to evaluate the neck dissection specimen.
Looking for future studies?
Notify MeAll sexes
Observational
Jackson, Mississippi, 39216, United States
This will be a retrospective study. All neck dissections received in the histology laboratory from Jan 2013 to December 2016 will be retrieved from the histopathology files by conducting a search through CoPath. The glass slides of all the neck dissections that fit the study criterion will be retrieved from the archives. The glass slides will be reviewed by the pathologist.
At the time of review number of lymph nodes identified microscopically, presence or absence of metastasis and if the Lymph Nodes (LN) were palpable or not palpable will be documented. The data will be analyzed to see if the submission of extra fat yielded any additional positive lymph nodes or microscopic deposits. The cost analysis for additional slides will be also done.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of submission of additional soft tissue in neck dissections for head and neck squamous cell carcinomas
Time frame: 3 years
Number of additional lymph nodes obtained with additional sampling of soft tissue
University of Mississippi Medical Center
Other
Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection Specimen in Its Entirety.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03652493
Castration-resistant Prostate Cancer, Metastasis
Caen, France
View Trial DetailsNCT06884839
Colonic Diseases, Colorectal Cancer
Minya, Minya Governorate, Egypt
View Trial DetailsNCT03644303
Circulating Tumour DNA, Genital Diseases
Manchester, Manchester Greater, United Kingdom
View Trial DetailsNCT06358001
Adenocarcinoma, Autoimmune Diseases
Orange, California, United States
View Trial Details